As FDA reviews CBD implications for women, industry watches anxiously

The hemp and CBD industry will be watching closely this week to find out whether federal regulators seem inclined to require warning labels for pregnant or nursing women on CBD products, or to mandate gender-specific dosing levels.

As FDA reviews CBD implications for women, industry watches anxiously is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs